We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
-35.35%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$140M
AUM Growth
-$455M
Cap. Flow
+$24.6M
Cap. Flow %
17.55%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
XLO icon
Xilio Therapeutics
XLO
+$24.6M
2
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$54.9K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLK
1
DELISTED
Allakos
ALLK
$47.9M 34.14%
4,887,932
– –
MIRM icon
2
Mirum Pharmaceuticals
MIRM
$6.08B
$30.6M 21.86%
1,921,118
– –
XLO icon
3
Xilio Therapeutics
XLO
$59.3M
$23.1M 16.45%
+102,960
New +$24.6M
OKUR
4
OnKure Therapeutics
OKUR
$155M
$20.6M 14.7%
240,922
– –
SPRB
5
Spruce Biosciences
SPRB
$182M
$9.58M 6.84%
28,644
– –
VAPO
6
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$8.43M 6.02%
50,896
+317
+0.6% +$54.9K

Similar funds

JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
QC
QCM Cayman Houston, Texas $3.63M AUM 61.13% 1-Year Est. Return
CU
Cornell University New York $3.44M AUM 9.69% 1-Year Est. Return
PWA
Pillar Wealth Advisors West Chester, Pennsylvania $3.35M AUM 22.3% 1-Year Est. Return

RiverVest Venture Management's Q4 2021 Portfolio in Review

As of Q4 2021, RiverVest Venture Management held 6 positions worth $140M, down 76% from $596M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RiverVest Venture Management deployed $24.6M of net new capital in Q4 2021, opening 1 new position and adding to 1 existing holding. Its largest new stake was Xilio Therapeutics: 102,960 shares worth $23.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management's largest Q4 2021 buy was Xilio Therapeutics: 102,960 shares worth $23.1M.
  • RiverVest Venture Management added most to Vapotherm, Inc. Common Stock in Q4 2021, an estimated $54.9K increase.
  • RiverVest Venture Management's ten largest holdings make up 100% of its $140M portfolio in Q4 2021.
  • RiverVest Venture Management opened 1 new position and closed 0 in Q4 2021.
  • RiverVest Venture Management's portfolio value fell 76% quarter-over-quarter to $140M.

Based on RiverVest Venture Management's 13F filing for Q4 2021, filed 7 Feb 2022.